So, dilution is a good thing, then?
Yeah, sure. Over 1B shares already added to the O/S, and 15B more through the warrants. Funny thing about those warrants, there’s a cashless exercise formula in them, which means they don’t have to give the company a plug nickel in cash to exercise them, just have to sacrifice some according to what the PPS is at the time of exercise.
And this company is still in debt. Auctus has $3.3M of a new convertible note (plus warrants) for their old note, plus $3.5M for their DIP and operational financing, so the overall debt was reduced by just over half.
And they still don’t have funding for their phase 2 trial.